Please login to the form below
ABPI
This page shows the latest ABPI news and features for those working in and with pharma, biotech and healthcare.
NICE’s long-serving chief exec Sir Andrew Dillon to step down
Mike Thompson, chief executive of the UK industry association the ABPI said:.
Latest news
-
New hires at Havas Life Medicom
She has also worked for the Office of Health Economics (part of the ABPI) helping to grow their health economics consultancy.
-
UK no longer measles-free as vaccination rates fall dramatically
Sheuli Porkess, executive director, ABPI. The vocal support from the prime minister has been welcomed by the pharma sector. ... for health emergencies such as Ebola outbreaks, helping care for an ageing population and keeping people healthy from
-
Government to set up ‘express freight service’ for medicinal products in event of no-deal Brexit
The Association of the British Pharmaceutical Industry (ABPI) has welcomed the additional measures, but still maintains that a no-deal Brexit is a worst-case scenario. ... However, we reiterate that securing a deal remains the best way to protect patients
-
Boris Johnson announces fast-track immigration plans for top scientists
Andrew Croydon, Head of Skills and Education at the ABPI.
-
Still no ferry contracts for no-deal Brexit medicines supplies
Above all, industry bodies like the BIA and pharma industry equivalent the ABPI say they want to avoid no-deal at all costs.
More from news
Approximately 91 fully matching, plus 495 partially matching documents found.
Latest Intelligence
-
Innovation and digital health comms recognised at Communiqué Awards
This wide variety of social media content helped the campaign reach its target audience more effectively than a pharma company could alone, while complying with ABPI and social channel regulations.
-
The UK’s new medicines pricing deal – opportunities and risks for pharma
Industry (ABPI) – to raise any issues with the management and operation of the scheme. ... The ABPI reacted strongly to this steep rise in charges, calling them “punitive” at the consultation stage last August.
-
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
UK pharma’s ABPI has made it plain that it wants as close alignment with Europe and the EMA as possible after Brexit, and sees virtually no advantages of following an
-
The UK’s new five-year pricing agreement
Industry leaders who have voiced their support for the deal include Novartis’ UK country president Haseeb Ahmad and EMIG’s chairman Leslie Galloway, who says the ABPI’s negotiating team had ... NHS England, with input from NICE and ABPI, committed
-
Brexit: can pharma 'take back control' of the narrative?
For this reason, as the clock ticks down, the sector urgently needs greater clarification across the five broad areas that have been identified by the ABPI and BIA: access to ... Nonetheless despite this, the ABPI has long-highlighted the need to bridge
More from intelligence
Approximately 8 fully matching, plus 43 partially matching documents found.
Latest appointments
-
New faces at imc, GCI Health and Lighthouse US
Additionally, she has also served as a member of the board of management of the ABPI, where she championed access and funding for patients with rare diseases.
-
Neurocentrx appoints two members to the board
His career history has seen him work in private equity and venture capital and he has been president of the ABPI.
-
Professor Carole Longson moves from NICE to the ABPI
Longson brings research, academic and pharmaceutical industry experience to the ABPI, including seven years as a research lead at GlaxoSmithKline. ... experience, expertise and network in both industry and academia will enable the ABPI to work with our
-
HCA appoints Mike Dixon as its new CEO
Commenting on behalf of the HCA Executive Committee, ABPI executive director of communications Aileen Thompson said: “We are really pleased that Mike has decided to lead the HCA at this critical
-
AZ's Lisa Anson elected president of ABPI
year. Anson joined the ABPI board in 2012 and has since overseen a number of schemes for the association, including the implementation of the Pharmaceutical Pricing Regulation Scheme. ... Speaking on behalf of the board and all staff at the ABPI, we very
More from appointments
Approximately 21 fully matching, plus 13 partially matching documents found.
Latest from PMHub
-
A patient view on the ABPI’s patient collaboration sourcebook
Last month, the ABPI released a much-in-demand document: The Working with Patients and Patient Organisations sourcebook. ... Last month, the ABPI released a much-in-demand document: T he Working with Patients and Patient Organisations sourcebook.
-
Modern alternatives to banner exhibition stands (why a reusable pharma exhibition stand could save you money)
Or a handy phone charger to draw people in. Of course, you’ll also need to be aware of any company restrictions, pharma industry regulations (ABPI), and local country regulations.
-
Pharma exhibition stand design: size doesn’t have to matter
Of course, you’ll also need to be aware of any company restrictions, pharma industry regulations (ABPI), and local country regulations.
-
Making a Difference - The Future of Pharma
On a global scale, pharma is one of the least-trusted industries. And this is despite the fact that pharma contributes more than £30 BN each year to the UK economy, supports almost 500, 000 jobs in the UK alone, and donated 1.4 BN treatments to the
-
OUTiCO growth in multi-channel creates more job openings
To succeed in this role you’ll need relevant experience in a key account management role, or similar, and be ABPI qualified.
More from PMHub
Approximately 3 fully matching, plus 24 partially matching documents found.
Featured jobs
- Account Director, Healthcare Communications
-
Salary TBC
- FREELANCE Account Director – Healthcare Advertising – London – 3...
-
Competitive Daily Rates
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Account Director – UK Office
-
Excellent salary and benefits
- Senior Account Executive – Account Manager – Healthcare Advertis...
-
£32000 - £43000 Bonus Benfits
Subscribe to our email news alerts
- Finch Therapeutics bags $53m for microbiome therapies
- MSD taps Austria’s Themis to bolster vaccine pipeline
- Early ‘no’ for GW Pharma’s epilepsy drug, but NICE vows to collaborate
- GSK preps filings for BCMA-targeting multiple myeloma drug
- Behaviour change – is there something missing?
- NICE’s long-serving chief exec Sir Andrew Dillon to step down
PMHub
Valid Insight
Valid Insight is an award-winning pharmaceutical global market access consultancy....
Latest intelligence
- Empowered patients: shaking the foundations of healthcare
- Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
- A uniquely English genomic medicine service
- The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
- Blended Intelligence
- Data is the most valued commodity of the modern world. For P&P it's all about the application....
Quick links
Infographics
